Fewer Women Getting Minimally Invasive Hysterectomies Since FDA Guidelines

Since the Food and Drug Administration (FDA) cautioned against using a minimally invasive method to treat fibroid tumors called power morcellation, there was a nearly quarter increase in hospital readmissions and 27 percent increase in major postoperative complications after hysterectomies in Michigan, a new University of Michigan study says. After the first FDA safety communication in April 2014, the percent of women receiving minimally invasive hysterectomies in a large Michigan database also went down by an absolute 1.7 percent decrease. The findings appear in the American Journal of Obstetrics&Gynecology. read more

Read the whole article on

More from